Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in POLITICO Morning eHealth, in “Surely You Must Be Postal.”
Following is an excerpt:
Brad Thompson, of Epstein, Becker & Green, told us that part of FDA's focus is disease risk claims. "FDA has been pretty steadfast for the last few years that when you make those sorts of claims to consumers, the product is a medical device.” Thompson doesn’t seem to be too worried for Sure, saying that it’s a “fairly gentle letter” in comparison to the typical medical device missive.